Ads by Google

Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009

NEEDHAM, Mass., Nov 05, 2009 (BUSINESS WIRE) --

Company: Celldex Therapeutics Inc (CLDX)

Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at Merriman Curhan Ford's 6th Annual Investor Summit at the Sofitel Hotel, New York City on Tuesday, November 10, 2009 at 2:40 pm, EST.

A live webcast of the 15-minute audio presentation will be available online at http://www.wsw.com/webcast/mcm12/cldx/ and on the "Presentations" page of the Investor Information section of Celldex's website at http://www.celldextherapeutics.com. An archive of the webcast will be available via Celldex's website for 90 days following the event.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.

About Merriman Curhan Ford

Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology. For more information, please go to www.mcfco.com.

SOURCE: Celldex Therapeutics, Inc. 

Celldex Therapeutics, Inc. 
Anthony S. Marucci, 781-433-0771 
President and CEO 
or 
Avery W. Catlin, 781-433-0771 
Chief Financial Officer 
IR@celldextherapeutics.com 
or 
Celldex Investor Relations: 
MacDougall Biomedical Communications 
Sarah Cavanaugh, 781-235-3060 
scavanaugh@macbiocom.com 
or 
Celldex Media: 
BMC Communications Group 
Matthew Driscoll, 212-477-9007 x20 
mdriscoll@bmccommunications.com

Copyright (C) 2009 BusinessWire. All rights reserved

News Provided by COMTEX

Company: Celldex Therapeutics Inc (CLDX)


Related terms: banking, cancer, ceo, consumer, corporate, disease, equity, financial services, health, hotel, internet, media, nasdaq, natural resources, new york, online, pipeline, president, research, technology

Related Articles

Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009 (Business Wire)
Nov 5, 2009
...Companies: Celldex Therapeutics, Inc...WIRE)--Celldex Therapeutics, Inc...Officer of Celldex Therapeutics, Inc., will present at Merriman Curhan Ford’s 6 th Annual Investor Summit at the Sofitel Hotel, New York City on...

New York Considers Resolution Backing Net Neutrality
Nov 20, 2009
Click Here New York Considers Resolution Backing Net Neutrality...11/20/2009 11:04:00 AM The New York City Council was scheduled to hold a...members. "The Council of the City of New York calls upon the Federal Communications...

Voltaire's CEO to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th in New York
Nov 4, 2009
...to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th in New York BILLERICA...will present at Merriman Curhan Ford’s 6th annual Investor Summit on November...at the Sofitel New York. The Voltaire...

Daniel Boulud Expands into London
Nov 9, 2009
...Daniel Boulud Expands into London The New York City-based French chef aims to open...It will be modeled on the Bar Boulud in New York and will offer a French bistro menu with... “As a French Chef who has made New York City my home for over 25 years, I have my...